Drug R&D 2025 is a key industry event showcasing the latest innovations in early-stage drug discovery and development. 

Sarah Bernard, our Senior Director BD North America, will be attending this premier gathering. She looks forward to engaging with industry leaders to discuss AI-driven drug discovery, emerging technologies, and new collaboration opportunities.

At Drug R&D 2025, Sarah will highlight Axxam’s expertise in advanced screening platforms, phenotypic drug discovery, and other cutting-edge solutions that accelerate innovation in the pharmaceutical industry.

If you’d like to schedule a meeting with Sarah, please reach out.

📅 Date: February 10–12, 2025
📍 Location: Boston, MA